Search Orphan Drug Designations and Approvals
-
Generic Name: | Pemigatinib |
---|---|
Date Designated: | 08/21/2019 |
Orphan Designation: | Treatment of myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2 |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Incyte Corporation 1801 Augustine Cut-Off Wilmington, Delaware 19803 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-